No response to first-line tenofovir+lamivudine+efavirenz despite optimization according to baseline resistance testing: impact of resistant minority variants on efficacy of low genetic barrier drugs.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples